ムスカリン作動薬
↑ “AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease”. J Mol Neurosci 19 (1–2): 145–53. (2002). doi:10.1007/s12031-002-0025-3. PMID 12212772.
↑ “M1 muscarinic agonists: Their potential in treatment and as disease-modifying agents in Alzheimer's disease”. Drug Development Research 50: 291–297. (2000). doi:10.1002/1098-2299(200007/08)50:3/4<291::aid-ddr12>3.0.co;2-6. オリジナルの2012-12-10時点におけるアーカイブ。. https://archive.today/20121210101949/http://www3.interscience.wiley.com/cgi-bin/abstract/73504595/ABSTRACT?CRETRY=1&SRETRY=0.
↑ Fisher A (July 2008). “Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease”.